Regeneron Pharmaceuticals holds the cleaner structural position, with stability as the main driver and valuation adding further support. Diageo still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, Regeneron Pharmaceuticals is in better shape — its trend is intact while Diageo's trend has broken down. That puts structure and market broadly in agreement — Regeneron Pharmaceuticals's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The comparison is mainly decided in stability, with the rest of the profile carrying less weight. The overall score gap is 11 points in favour of Regeneron Pharmaceuticals, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The clearest structural overlap shows up in recent revenue growth and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in stability.
Left means cheaper relative valuation. Higher means stronger structure.
Regeneron Pharmaceuticals, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The clearest distance comes from a steadier profile over time.
Market confirmation also leans toward Regeneron Pharmaceuticals, Inc., which makes the lead look better backed by actual market behaviour.
Stability is the clearest driver of the lead, with valuation adding further support — though growth still provides a real counterweight.
Break down the DGE.L vs REGN comparison across all dimensions with the full interactive tool.
Explore how DGE.L and REGN each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.